nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—PTGS1—ulcerative colitis	0.277	1	CbGaD
Montelukast—ALOX5—Olsalazine—ulcerative colitis	0.135	0.223	CbGbCtD
Montelukast—ALOX5—Balsalazide—ulcerative colitis	0.12	0.198	CbGbCtD
Montelukast—ALOX5—Mesalazine—ulcerative colitis	0.0962	0.159	CbGbCtD
Montelukast—ALOX5—Sulfasalazine—ulcerative colitis	0.0537	0.0886	CbGbCtD
Montelukast—PTGS1—Olsalazine—ulcerative colitis	0.0303	0.05	CbGbCtD
Montelukast—PTGS1—Balsalazide—ulcerative colitis	0.027	0.0446	CbGbCtD
Montelukast—PTGS1—Mesalazine—ulcerative colitis	0.0216	0.0356	CbGbCtD
Montelukast—CYP2A6—Nicotine—ulcerative colitis	0.0182	0.03	CbGbCtD
Montelukast—PTGS1—Sulfasalazine—ulcerative colitis	0.0121	0.0199	CbGbCtD
Montelukast—CYP2A6—Prednisolone—ulcerative colitis	0.012	0.0197	CbGbCtD
Montelukast—CYP2C8—Nicotine—ulcerative colitis	0.00896	0.0148	CbGbCtD
Montelukast—CYP3A4—Budesonide—ulcerative colitis	0.00835	0.0138	CbGbCtD
Montelukast—CYP2C8—Cholecalciferol—ulcerative colitis	0.00804	0.0133	CbGbCtD
Montelukast—CYP2A6—Dexamethasone—ulcerative colitis	0.00705	0.0116	CbGbCtD
Montelukast—CYP2C9—Nicotine—ulcerative colitis	0.00625	0.0103	CbGbCtD
Montelukast—CYP2C9—Cholecalciferol—ulcerative colitis	0.00561	0.00925	CbGbCtD
Montelukast—CYP2C8—Hydrocortisone—ulcerative colitis	0.00559	0.00922	CbGbCtD
Montelukast—CYP3A4—Methylprednisolone—ulcerative colitis	0.00373	0.00615	CbGbCtD
Montelukast—CYP3A4—Nicotine—ulcerative colitis	0.00363	0.00599	CbGbCtD
Montelukast—CYP2C8—Dexamethasone—ulcerative colitis	0.00348	0.00574	CbGbCtD
Montelukast—CYP3A4—Cholecalciferol—ulcerative colitis	0.00326	0.00538	CbGbCtD
Montelukast—CYP3A4—Triamcinolone—ulcerative colitis	0.00283	0.00466	CbGbCtD
Montelukast—CYP2C9—Dexamethasone—ulcerative colitis	0.00243	0.004	CbGbCtD
Montelukast—CYP3A4—Betamethasone—ulcerative colitis	0.00242	0.004	CbGbCtD
Montelukast—CYP3A4—Prednisolone—ulcerative colitis	0.00239	0.00395	CbGbCtD
Montelukast—CYP3A4—Hydrocortisone—ulcerative colitis	0.00227	0.00374	CbGbCtD
Montelukast—CYP3A4—Prednisone—ulcerative colitis	0.00226	0.00373	CbGbCtD
Montelukast—CYP3A4—Dexamethasone—ulcerative colitis	0.00141	0.00233	CbGbCtD
Montelukast—CYSLTR1—Eicosanoid ligand-binding receptors—PTGER4—ulcerative colitis	0.00121	0.0701	CbGpPWpGaD
Montelukast—PTGS1—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.000936	0.0541	CbGpPWpGaD
Montelukast—ALOX5—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000635	0.0367	CbGpPWpGaD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.000536	0.031	CbGpPWpGaD
Montelukast—CYSLTR1—Endothelins—GNA12—ulcerative colitis	0.00049	0.0283	CbGpPWpGaD
Montelukast—SLCO2B1—Transport of organic anions—ALB—ulcerative colitis	0.000483	0.0279	CbGpPWpGaD
Montelukast—ALOX5—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000353	0.0204	CbGpPWpGaD
Montelukast—SLCO2B1—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000291	0.0168	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—SLC39A11—ulcerative colitis	0.000269	0.0155	CbGpPWpGaD
Montelukast—CYSLTR1—Endothelins—ADCY5—ulcerative colitis	0.000247	0.0143	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000244	0.0141	CbGpPWpGaD
Montelukast—ALOX5—Eicosanoid Synthesis—PTGS2—ulcerative colitis	0.000244	0.0141	CbGpPWpGaD
Montelukast—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000234	0.0135	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000225	0.013	CbGpPWpGaD
Montelukast—CYSLTR1—Endothelins—MMP1—ulcerative colitis	0.000219	0.0127	CbGpPWpGaD
Montelukast—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.000208	0.012	CbGpPWpGaD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000192	0.0111	CbGpPWpGaD
Montelukast—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	0.00019	0.011	CbGpPWpGaD
Montelukast—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—ulcerative colitis	0.000179	0.0103	CbGpPWpGaD
Montelukast—SLCO2B1—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000171	0.00991	CbGpPWpGaD
Montelukast—SLCO2B1—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000171	0.00991	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000165	0.00952	CbGpPWpGaD
Montelukast—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.000163	0.00939	CbGpPWpGaD
Montelukast—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000161	0.00931	CbGpPWpGaD
Montelukast—CYSLTR1—Endothelins—JAK2—ulcerative colitis	0.000154	0.00891	CbGpPWpGaD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00015	0.00869	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000148	0.00854	CbGpPWpGaD
Montelukast—CYSLTR1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000147	0.00852	CbGpPWpGaD
Montelukast—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000145	0.00837	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000145	0.00836	CbGpPWpGaD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000141	0.00817	CbGpPWpGaD
Montelukast—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—ulcerative colitis	0.000138	0.00798	CbGpPWpGaD
Montelukast—ALOX5—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000135	0.00782	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000132	0.00762	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000129	0.00745	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—CRP—ulcerative colitis	0.000128	0.00742	CbGpPWpGaD
Montelukast—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	0.000127	0.00736	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.000125	0.00725	CbGpPWpGaD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000125	0.0072	CbGpPWpGaD
Montelukast—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000123	0.00713	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000121	0.007	CbGpPWpGaD
Montelukast—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.00012	0.00693	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.000118	0.00682	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—CCL20—ulcerative colitis	0.00011	0.00636	CbGpPWpGaD
Montelukast—Hallucination—Methylprednisolone—ulcerative colitis	0.000108	0.00108	CcSEcCtD
Montelukast—Pharyngitis—Triamcinolone—ulcerative colitis	0.000108	0.00108	CcSEcCtD
Montelukast—Neuropathy peripheral—Dexamethasone—ulcerative colitis	0.000107	0.00108	CcSEcCtD
Montelukast—Neuropathy peripheral—Betamethasone—ulcerative colitis	0.000107	0.00108	CcSEcCtD
Montelukast—SLCO2B1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000107	0.00617	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000107	0.00616	CbGpPWpGaD
Montelukast—Conjunctivitis—Dexamethasone—ulcerative colitis	0.000107	0.00107	CcSEcCtD
Montelukast—Conjunctivitis—Betamethasone—ulcerative colitis	0.000107	0.00107	CcSEcCtD
Montelukast—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000106	0.00107	CcSEcCtD
Montelukast—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000106	0.00612	CbGpPWpGaD
Montelukast—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	0.000106	0.0061	CbGpPWpGaD
Montelukast—Pancreatitis—Prednisone—ulcerative colitis	0.000105	0.00106	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000105	0.00105	CcSEcCtD
Montelukast—Hypersensitivity—Budesonide—ulcerative colitis	0.000104	0.00105	CcSEcCtD
Montelukast—Insomnia—Mesalazine—ulcerative colitis	0.000104	0.00105	CcSEcCtD
Montelukast—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000104	0.00105	CcSEcCtD
Montelukast—Paraesthesia—Mesalazine—ulcerative colitis	0.000103	0.00104	CcSEcCtD
Montelukast—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000103	0.00104	CcSEcCtD
Montelukast—Somnolence—Mesalazine—ulcerative colitis	0.000102	0.00103	CcSEcCtD
Montelukast—Asthenia—Budesonide—ulcerative colitis	0.000102	0.00102	CcSEcCtD
Montelukast—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000101	0.00586	CbGpPWpGaD
Montelukast—Dyspepsia—Mesalazine—ulcerative colitis	0.000101	0.00102	CcSEcCtD
Montelukast—Mental disorder—Hydrocortisone—ulcerative colitis	0.000101	0.00101	CcSEcCtD
Montelukast—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.0001	0.00101	CcSEcCtD
Montelukast—Pruritus—Budesonide—ulcerative colitis	0.0001	0.00101	CcSEcCtD
Montelukast—Abdominal pain—Azathioprine—ulcerative colitis	9.99e-05	0.001	CcSEcCtD
Montelukast—Body temperature increased—Azathioprine—ulcerative colitis	9.99e-05	0.001	CcSEcCtD
Montelukast—Gastrointestinal disorder—Mesalazine—ulcerative colitis	9.93e-05	0.000999	CcSEcCtD
Montelukast—Fatigue—Mesalazine—ulcerative colitis	9.92e-05	0.000998	CcSEcCtD
Montelukast—CYP2C8—Arachidonic acid metabolism—PTGS1—ulcerative colitis	9.89e-05	0.00572	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—ALB—ulcerative colitis	9.84e-05	0.00569	CbGpPWpGaD
Montelukast—Pain—Mesalazine—ulcerative colitis	9.84e-05	0.000989	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—CXCR2—ulcerative colitis	9.81e-05	0.00567	CbGpPWpGaD
Montelukast—Hallucination—Dexamethasone—ulcerative colitis	9.79e-05	0.000984	CcSEcCtD
Montelukast—Hallucination—Betamethasone—ulcerative colitis	9.79e-05	0.000984	CcSEcCtD
Montelukast—Immune system disorder—Methylprednisolone—ulcerative colitis	9.77e-05	0.000983	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	9.77e-05	0.00564	CbGpPWpGaD
Montelukast—Mediastinal disorder—Methylprednisolone—ulcerative colitis	9.75e-05	0.000981	CcSEcCtD
Montelukast—Diarrhoea—Budesonide—ulcerative colitis	9.68e-05	0.000973	CcSEcCtD
Montelukast—Mental disorder—Methylprednisolone—ulcerative colitis	9.48e-05	0.000953	CcSEcCtD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	9.44e-05	0.00545	CbGpPWpGaD
Montelukast—Gastrointestinal pain—Mesalazine—ulcerative colitis	9.41e-05	0.000946	CcSEcCtD
Montelukast—Angioedema—Prednisolone—ulcerative colitis	9.38e-05	0.000943	CcSEcCtD
Montelukast—Neuropathy peripheral—Prednisone—ulcerative colitis	9.36e-05	0.000941	CcSEcCtD
Montelukast—Dizziness—Budesonide—ulcerative colitis	9.36e-05	0.000941	CcSEcCtD
Montelukast—Hypersensitivity—Azathioprine—ulcerative colitis	9.31e-05	0.000936	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—CCR6—ulcerative colitis	9.23e-05	0.00533	CbGpPWpGaD
Montelukast—Angioedema—Hydrocortisone—ulcerative colitis	9.16e-05	0.000921	CcSEcCtD
Montelukast—Urticaria—Mesalazine—ulcerative colitis	9.14e-05	0.000919	CcSEcCtD
Montelukast—Abdominal pain—Mesalazine—ulcerative colitis	9.1e-05	0.000915	CcSEcCtD
Montelukast—Body temperature increased—Mesalazine—ulcerative colitis	9.1e-05	0.000915	CcSEcCtD
Montelukast—Vomiting—Budesonide—ulcerative colitis	9e-05	0.000905	CcSEcCtD
Montelukast—ALOX5—Selenium Micronutrient Network—IFNG—ulcerative colitis	8.98e-05	0.00519	CbGpPWpGaD
Montelukast—Rash—Budesonide—ulcerative colitis	8.92e-05	0.000897	CcSEcCtD
Montelukast—Dermatitis—Budesonide—ulcerative colitis	8.91e-05	0.000896	CcSEcCtD
Montelukast—Convulsion—Prednisolone—ulcerative colitis	8.89e-05	0.000894	CcSEcCtD
Montelukast—Headache—Budesonide—ulcerative colitis	8.86e-05	0.000891	CcSEcCtD
Montelukast—ALOX5—Selenium Micronutrient Network—RELA—ulcerative colitis	8.86e-05	0.00512	CbGpPWpGaD
Montelukast—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	8.83e-05	0.0051	CbGpPWpGaD
Montelukast—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	8.81e-05	0.00509	CbGpPWpGaD
Montelukast—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	8.8e-05	0.00508	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	8.71e-05	0.00503	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	8.71e-05	0.00503	CbGpPWpGaD
Montelukast—Convulsion—Hydrocortisone—ulcerative colitis	8.69e-05	0.000873	CcSEcCtD
Montelukast—Diarrhoea—Azathioprine—ulcerative colitis	8.64e-05	0.000869	CcSEcCtD
Montelukast—Angioedema—Triamcinolone—ulcerative colitis	8.63e-05	0.000867	CcSEcCtD
Montelukast—ALOX5—Selenium Micronutrient Network—PTGS2—ulcerative colitis	8.61e-05	0.00498	CbGpPWpGaD
Montelukast—Angioedema—Methylprednisolone—ulcerative colitis	8.61e-05	0.000865	CcSEcCtD
Montelukast—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	8.59e-05	0.00497	CbGpPWpGaD
Montelukast—Myalgia—Hydrocortisone—ulcerative colitis	8.54e-05	0.000858	CcSEcCtD
Montelukast—Hallucination—Prednisone—ulcerative colitis	8.53e-05	0.000857	CcSEcCtD
Montelukast—Anxiety—Hydrocortisone—ulcerative colitis	8.51e-05	0.000855	CcSEcCtD
Montelukast—Hypersensitivity—Mesalazine—ulcerative colitis	8.48e-05	0.000852	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	8.48e-05	0.000852	CcSEcCtD
Montelukast—Connective tissue disorder—Prednisone—ulcerative colitis	8.42e-05	0.000847	CcSEcCtD
Montelukast—Nausea—Budesonide—ulcerative colitis	8.4e-05	0.000845	CcSEcCtD
Montelukast—Anaphylactic shock—Prednisolone—ulcerative colitis	8.38e-05	0.000842	CcSEcCtD
Montelukast—Oedema—Prednisolone—ulcerative colitis	8.38e-05	0.000842	CcSEcCtD
Montelukast—Dizziness—Azathioprine—ulcerative colitis	8.35e-05	0.00084	CcSEcCtD
Montelukast—Asthenia—Mesalazine—ulcerative colitis	8.26e-05	0.00083	CcSEcCtD
Montelukast—Cough—Triamcinolone—ulcerative colitis	8.24e-05	0.000828	CcSEcCtD
Montelukast—Oedema—Hydrocortisone—ulcerative colitis	8.18e-05	0.000823	CcSEcCtD
Montelukast—Anaphylactic shock—Hydrocortisone—ulcerative colitis	8.18e-05	0.000823	CcSEcCtD
Montelukast—Convulsion—Triamcinolone—ulcerative colitis	8.18e-05	0.000822	CcSEcCtD
Montelukast—Convulsion—Methylprednisolone—ulcerative colitis	8.16e-05	0.000821	CcSEcCtD
Montelukast—Pruritus—Mesalazine—ulcerative colitis	8.14e-05	0.000819	CcSEcCtD
Montelukast—Infection—Hydrocortisone—ulcerative colitis	8.13e-05	0.000817	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—PTGER4—ulcerative colitis	8.12e-05	0.00469	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	8.09e-05	0.00467	CbGpPWpGaD
Montelukast—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	8.06e-05	0.00466	CbGpPWpGaD
Montelukast—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	8.05e-05	0.00465	CbGpPWpGaD
Montelukast—Myalgia—Triamcinolone—ulcerative colitis	8.04e-05	0.000808	CcSEcCtD
Montelukast—Vomiting—Azathioprine—ulcerative colitis	8.03e-05	0.000808	CcSEcCtD
Montelukast—Nervous system disorder—Hydrocortisone—ulcerative colitis	8.02e-05	0.000807	CcSEcCtD
Montelukast—Arthralgia—Methylprednisolone—ulcerative colitis	8.02e-05	0.000806	CcSEcCtD
Montelukast—Myalgia—Methylprednisolone—ulcerative colitis	8.02e-05	0.000806	CcSEcCtD
Montelukast—ALOX5—Selenium Micronutrient Network—IL1B—ulcerative colitis	8.01e-05	0.00463	CbGpPWpGaD
Montelukast—Anxiety—Methylprednisolone—ulcerative colitis	7.99e-05	0.000804	CcSEcCtD
Montelukast—Rash—Azathioprine—ulcerative colitis	7.97e-05	0.000801	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	7.96e-05	0.000801	CcSEcCtD
Montelukast—Dermatitis—Azathioprine—ulcerative colitis	7.96e-05	0.0008	CcSEcCtD
Montelukast—Skin disorder—Hydrocortisone—ulcerative colitis	7.95e-05	0.000799	CcSEcCtD
Montelukast—Headache—Azathioprine—ulcerative colitis	7.91e-05	0.000796	CcSEcCtD
Montelukast—Diarrhoea—Mesalazine—ulcerative colitis	7.87e-05	0.000792	CcSEcCtD
Montelukast—Angioedema—Dexamethasone—ulcerative colitis	7.83e-05	0.000787	CcSEcCtD
Montelukast—Angioedema—Betamethasone—ulcerative colitis	7.83e-05	0.000787	CcSEcCtD
Montelukast—Immune system disorder—Prednisone—ulcerative colitis	7.74e-05	0.000778	CcSEcCtD
Montelukast—Anaphylactic shock—Triamcinolone—ulcerative colitis	7.7e-05	0.000775	CcSEcCtD
Montelukast—Oedema—Triamcinolone—ulcerative colitis	7.7e-05	0.000775	CcSEcCtD
Montelukast—Anaphylactic shock—Methylprednisolone—ulcerative colitis	7.69e-05	0.000773	CcSEcCtD
Montelukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7.68e-05	0.00444	CbGpPWpGaD
Montelukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	7.66e-05	0.00443	CbGpPWpGaD
Montelukast—Infection—Triamcinolone—ulcerative colitis	7.65e-05	0.00077	CcSEcCtD
Montelukast—Infection—Methylprednisolone—ulcerative colitis	7.64e-05	0.000768	CcSEcCtD
Montelukast—Dizziness—Mesalazine—ulcerative colitis	7.61e-05	0.000765	CcSEcCtD
Montelukast—Insomnia—Prednisolone—ulcerative colitis	7.58e-05	0.000762	CcSEcCtD
Montelukast—Nervous system disorder—Methylprednisolone—ulcerative colitis	7.54e-05	0.000758	CcSEcCtD
Montelukast—Paraesthesia—Prednisolone—ulcerative colitis	7.52e-05	0.000756	CcSEcCtD
Montelukast—Mental disorder—Prednisone—ulcerative colitis	7.51e-05	0.000755	CcSEcCtD
Montelukast—Nausea—Azathioprine—ulcerative colitis	7.5e-05	0.000755	CcSEcCtD
Montelukast—ALOX5—Selenium Micronutrient Network—NFKB1—ulcerative colitis	7.47e-05	0.00432	CbGpPWpGaD
Montelukast—Skin disorder—Methylprednisolone—ulcerative colitis	7.47e-05	0.000751	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	7.46e-05	0.00075	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—GHRL—ulcerative colitis	7.44e-05	0.0043	CbGpPWpGaD
Montelukast—Convulsion—Betamethasone—ulcerative colitis	7.42e-05	0.000746	CcSEcCtD
Montelukast—Convulsion—Dexamethasone—ulcerative colitis	7.42e-05	0.000746	CcSEcCtD
Montelukast—Insomnia—Hydrocortisone—ulcerative colitis	7.4e-05	0.000744	CcSEcCtD
Montelukast—Paraesthesia—Hydrocortisone—ulcerative colitis	7.35e-05	0.000739	CcSEcCtD
Montelukast—Vomiting—Mesalazine—ulcerative colitis	7.32e-05	0.000736	CcSEcCtD
Montelukast—Myalgia—Betamethasone—ulcerative colitis	7.29e-05	0.000733	CcSEcCtD
Montelukast—Myalgia—Dexamethasone—ulcerative colitis	7.29e-05	0.000733	CcSEcCtD
Montelukast—Anxiety—Dexamethasone—ulcerative colitis	7.27e-05	0.000731	CcSEcCtD
Montelukast—Anxiety—Betamethasone—ulcerative colitis	7.27e-05	0.000731	CcSEcCtD
Montelukast—Rash—Mesalazine—ulcerative colitis	7.26e-05	0.00073	CcSEcCtD
Montelukast—Dermatitis—Mesalazine—ulcerative colitis	7.25e-05	0.000729	CcSEcCtD
Montelukast—Headache—Mesalazine—ulcerative colitis	7.21e-05	0.000725	CcSEcCtD
Montelukast—Dyspepsia—Hydrocortisone—ulcerative colitis	7.2e-05	0.000724	CcSEcCtD
Montelukast—Pain—Prednisolone—ulcerative colitis	7.16e-05	0.00072	CcSEcCtD
Montelukast—CYSLTR1—GPCR downstream signaling—CXCR1—ulcerative colitis	7.09e-05	0.0041	CbGpPWpGaD
Montelukast—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	7.06e-05	0.00071	CcSEcCtD
Montelukast—Fatigue—Hydrocortisone—ulcerative colitis	7.05e-05	0.000709	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	7.02e-05	0.000706	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	7e-05	0.000704	CcSEcCtD
Montelukast—Pain—Hydrocortisone—ulcerative colitis	7e-05	0.000704	CcSEcCtD
Montelukast—Anaphylactic shock—Betamethasone—ulcerative colitis	6.99e-05	0.000703	CcSEcCtD
Montelukast—Anaphylactic shock—Dexamethasone—ulcerative colitis	6.99e-05	0.000703	CcSEcCtD
Montelukast—Oedema—Betamethasone—ulcerative colitis	6.99e-05	0.000703	CcSEcCtD
Montelukast—Oedema—Dexamethasone—ulcerative colitis	6.99e-05	0.000703	CcSEcCtD
Montelukast—Insomnia—Triamcinolone—ulcerative colitis	6.97e-05	0.000701	CcSEcCtD
Montelukast—Insomnia—Methylprednisolone—ulcerative colitis	6.95e-05	0.000699	CcSEcCtD
Montelukast—Infection—Dexamethasone—ulcerative colitis	6.95e-05	0.000698	CcSEcCtD
Montelukast—Infection—Betamethasone—ulcerative colitis	6.95e-05	0.000698	CcSEcCtD
Montelukast—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	6.93e-05	0.00401	CbGpPWpGaD
Montelukast—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.93e-05	0.00401	CbGpPWpGaD
Montelukast—Paraesthesia—Triamcinolone—ulcerative colitis	6.92e-05	0.000696	CcSEcCtD
Montelukast—Paraesthesia—Methylprednisolone—ulcerative colitis	6.9e-05	0.000694	CcSEcCtD
Montelukast—Nervous system disorder—Dexamethasone—ulcerative colitis	6.86e-05	0.000689	CcSEcCtD
Montelukast—Nervous system disorder—Betamethasone—ulcerative colitis	6.86e-05	0.000689	CcSEcCtD
Montelukast—Agitation—Prednisone—ulcerative colitis	6.86e-05	0.000689	CcSEcCtD
Montelukast—Thrombocytopenia—Betamethasone—ulcerative colitis	6.85e-05	0.000688	CcSEcCtD
Montelukast—Thrombocytopenia—Dexamethasone—ulcerative colitis	6.85e-05	0.000688	CcSEcCtD
Montelukast—Nausea—Mesalazine—ulcerative colitis	6.84e-05	0.000687	CcSEcCtD
Montelukast—Angioedema—Prednisone—ulcerative colitis	6.82e-05	0.000685	CcSEcCtD
Montelukast—Dyspepsia—Triamcinolone—ulcerative colitis	6.78e-05	0.000682	CcSEcCtD
Montelukast—Dyspepsia—Methylprednisolone—ulcerative colitis	6.77e-05	0.00068	CcSEcCtD
Montelukast—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	6.69e-05	0.000673	CcSEcCtD
Montelukast—Urticaria—Prednisolone—ulcerative colitis	6.66e-05	0.000669	CcSEcCtD
Montelukast—Fatigue—Triamcinolone—ulcerative colitis	6.64e-05	0.000668	CcSEcCtD
Montelukast—Fatigue—Methylprednisolone—ulcerative colitis	6.63e-05	0.000666	CcSEcCtD
Montelukast—Pain—Triamcinolone—ulcerative colitis	6.59e-05	0.000662	CcSEcCtD
Montelukast—Urticaria—Hydrocortisone—ulcerative colitis	6.5e-05	0.000654	CcSEcCtD
Montelukast—Body temperature increased—Hydrocortisone—ulcerative colitis	6.47e-05	0.00065	CcSEcCtD
Montelukast—Abdominal pain—Hydrocortisone—ulcerative colitis	6.47e-05	0.00065	CcSEcCtD
Montelukast—Convulsion—Prednisone—ulcerative colitis	6.46e-05	0.00065	CcSEcCtD
Montelukast—CYSLTR1—Signaling by GPCR—CXCR1—ulcerative colitis	6.44e-05	0.00372	CbGpPWpGaD
Montelukast—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.37e-05	0.00064	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.37e-05	0.00064	CcSEcCtD
Montelukast—Arthralgia—Prednisone—ulcerative colitis	6.35e-05	0.000639	CcSEcCtD
Montelukast—Myalgia—Prednisone—ulcerative colitis	6.35e-05	0.000639	CcSEcCtD
Montelukast—Anxiety—Prednisone—ulcerative colitis	6.33e-05	0.000636	CcSEcCtD
Montelukast—Insomnia—Dexamethasone—ulcerative colitis	6.32e-05	0.000636	CcSEcCtD
Montelukast—Insomnia—Betamethasone—ulcerative colitis	6.32e-05	0.000636	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	6.31e-05	0.000634	CcSEcCtD
Montelukast—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.29e-05	0.000632	CcSEcCtD
Montelukast—Paraesthesia—Betamethasone—ulcerative colitis	6.28e-05	0.000631	CcSEcCtD
Montelukast—Paraesthesia—Dexamethasone—ulcerative colitis	6.28e-05	0.000631	CcSEcCtD
Montelukast—CYSLTR1—GPCR downstream signaling—CCL20—ulcerative colitis	6.22e-05	0.0036	CbGpPWpGaD
Montelukast—Hypersensitivity—Prednisolone—ulcerative colitis	6.17e-05	0.000621	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—ADRB2—ulcerative colitis	6.16e-05	0.00356	CbGpPWpGaD
Montelukast—Dyspepsia—Betamethasone—ulcerative colitis	6.15e-05	0.000619	CcSEcCtD
Montelukast—Dyspepsia—Dexamethasone—ulcerative colitis	6.15e-05	0.000619	CcSEcCtD
Montelukast—Urticaria—Triamcinolone—ulcerative colitis	6.12e-05	0.000615	CcSEcCtD
Montelukast—Urticaria—Methylprednisolone—ulcerative colitis	6.11e-05	0.000614	CcSEcCtD
Montelukast—Body temperature increased—Triamcinolone—ulcerative colitis	6.09e-05	0.000612	CcSEcCtD
Montelukast—Anaphylactic shock—Prednisone—ulcerative colitis	6.09e-05	0.000612	CcSEcCtD
Montelukast—Oedema—Prednisone—ulcerative colitis	6.09e-05	0.000612	CcSEcCtD
Montelukast—Abdominal pain—Methylprednisolone—ulcerative colitis	6.08e-05	0.000611	CcSEcCtD
Montelukast—Infection—Prednisone—ulcerative colitis	6.05e-05	0.000608	CcSEcCtD
Montelukast—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	6.04e-05	0.000607	CcSEcCtD
Montelukast—Gastrointestinal disorder—Betamethasone—ulcerative colitis	6.04e-05	0.000607	CcSEcCtD
Montelukast—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.03e-05	0.000606	CcSEcCtD
Montelukast—Fatigue—Betamethasone—ulcerative colitis	6.03e-05	0.000606	CcSEcCtD
Montelukast—Fatigue—Dexamethasone—ulcerative colitis	6.03e-05	0.000606	CcSEcCtD
Montelukast—Pain—Betamethasone—ulcerative colitis	5.98e-05	0.000601	CcSEcCtD
Montelukast—Pain—Dexamethasone—ulcerative colitis	5.98e-05	0.000601	CcSEcCtD
Montelukast—Nervous system disorder—Prednisone—ulcerative colitis	5.97e-05	0.0006	CcSEcCtD
Montelukast—Skin disorder—Prednisone—ulcerative colitis	5.91e-05	0.000595	CcSEcCtD
Montelukast—Asthenia—Hydrocortisone—ulcerative colitis	5.87e-05	0.00059	CcSEcCtD
Montelukast—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	5.87e-05	0.00339	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—GNA12—ulcerative colitis	5.85e-05	0.00338	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—TNF—ulcerative colitis	5.81e-05	0.00336	CbGpPWpGaD
Montelukast—Pruritus—Hydrocortisone—ulcerative colitis	5.79e-05	0.000582	CcSEcCtD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	5.78e-05	0.00334	CbGpPWpGaD
Montelukast—Gastrointestinal pain—Betamethasone—ulcerative colitis	5.72e-05	0.000575	CcSEcCtD
Montelukast—Gastrointestinal pain—Dexamethasone—ulcerative colitis	5.72e-05	0.000575	CcSEcCtD
Montelukast—Hypersensitivity—Triamcinolone—ulcerative colitis	5.68e-05	0.000571	CcSEcCtD
Montelukast—Hypersensitivity—Methylprednisolone—ulcerative colitis	5.66e-05	0.00057	CcSEcCtD
Montelukast—CYSLTR1—Signaling by GPCR—CCL20—ulcerative colitis	5.65e-05	0.00327	CbGpPWpGaD
Montelukast—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.64e-05	0.00326	CbGpPWpGaD
Montelukast—Diarrhoea—Hydrocortisone—ulcerative colitis	5.6e-05	0.000563	CcSEcCtD
Montelukast—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	5.57e-05	0.00322	CbGpPWpGaD
Montelukast—Urticaria—Dexamethasone—ulcerative colitis	5.55e-05	0.000558	CcSEcCtD
Montelukast—Urticaria—Betamethasone—ulcerative colitis	5.55e-05	0.000558	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Prednisone—ulcerative colitis	5.55e-05	0.000558	CcSEcCtD
Montelukast—CYSLTR1—GPCR downstream signaling—CXCR2—ulcerative colitis	5.55e-05	0.00321	CbGpPWpGaD
Montelukast—Dizziness—Prednisolone—ulcerative colitis	5.54e-05	0.000557	CcSEcCtD
Montelukast—Asthenia—Triamcinolone—ulcerative colitis	5.53e-05	0.000556	CcSEcCtD
Montelukast—Abdominal pain—Betamethasone—ulcerative colitis	5.53e-05	0.000556	CcSEcCtD
Montelukast—Abdominal pain—Dexamethasone—ulcerative colitis	5.53e-05	0.000556	CcSEcCtD
Montelukast—Body temperature increased—Dexamethasone—ulcerative colitis	5.53e-05	0.000556	CcSEcCtD
Montelukast—Body temperature increased—Betamethasone—ulcerative colitis	5.53e-05	0.000556	CcSEcCtD
Montelukast—Asthenia—Methylprednisolone—ulcerative colitis	5.52e-05	0.000555	CcSEcCtD
Montelukast—Insomnia—Prednisone—ulcerative colitis	5.51e-05	0.000554	CcSEcCtD
Montelukast—Paraesthesia—Prednisone—ulcerative colitis	5.47e-05	0.00055	CcSEcCtD
Montelukast—Pruritus—Triamcinolone—ulcerative colitis	5.45e-05	0.000548	CcSEcCtD
Montelukast—Pruritus—Methylprednisolone—ulcerative colitis	5.44e-05	0.000547	CcSEcCtD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.43e-05	0.00314	CbGpPWpGaD
Montelukast—Dizziness—Hydrocortisone—ulcerative colitis	5.41e-05	0.000544	CcSEcCtD
Montelukast—CYP2A6—Biological oxidations—PTGS1—ulcerative colitis	5.39e-05	0.00311	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CHP1—ulcerative colitis	5.39e-05	0.00311	CbGpPWpGaD
Montelukast—Dyspepsia—Prednisone—ulcerative colitis	5.36e-05	0.000539	CcSEcCtD
Montelukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.34e-05	0.00309	CbGpPWpGaD
Montelukast—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	5.31e-05	0.00307	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—GNA12—ulcerative colitis	5.31e-05	0.00307	CbGpPWpGaD
Montelukast—Rash—Prednisolone—ulcerative colitis	5.28e-05	0.000531	CcSEcCtD
Montelukast—Dermatitis—Prednisolone—ulcerative colitis	5.28e-05	0.000531	CcSEcCtD
Montelukast—Diarrhoea—Methylprednisolone—ulcerative colitis	5.26e-05	0.000529	CcSEcCtD
Montelukast—Fatigue—Prednisone—ulcerative colitis	5.25e-05	0.000528	CcSEcCtD
Montelukast—Headache—Prednisolone—ulcerative colitis	5.25e-05	0.000528	CcSEcCtD
Montelukast—CYSLTR1—GPCR downstream signaling—CCR6—ulcerative colitis	5.21e-05	0.00301	CbGpPWpGaD
Montelukast—Vomiting—Hydrocortisone—ulcerative colitis	5.2e-05	0.000523	CcSEcCtD
Montelukast—Rash—Hydrocortisone—ulcerative colitis	5.16e-05	0.000519	CcSEcCtD
Montelukast—Dermatitis—Hydrocortisone—ulcerative colitis	5.15e-05	0.000518	CcSEcCtD
Montelukast—Headache—Hydrocortisone—ulcerative colitis	5.13e-05	0.000515	CcSEcCtD
Montelukast—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	5.12e-05	0.00296	CbGpPWpGaD
Montelukast—Dizziness—Triamcinolone—ulcerative colitis	5.1e-05	0.000512	CcSEcCtD
Montelukast—Dizziness—Methylprednisolone—ulcerative colitis	5.08e-05	0.000511	CcSEcCtD
Montelukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	5.06e-05	0.00293	CbGpPWpGaD
Montelukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	5.05e-05	0.00292	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.05e-05	0.00292	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CXCR2—ulcerative colitis	5.04e-05	0.00291	CbGpPWpGaD
Montelukast—Asthenia—Dexamethasone—ulcerative colitis	5.02e-05	0.000504	CcSEcCtD
Montelukast—Asthenia—Betamethasone—ulcerative colitis	5.02e-05	0.000504	CcSEcCtD
Montelukast—Gastrointestinal pain—Prednisone—ulcerative colitis	4.98e-05	0.000501	CcSEcCtD
Montelukast—Nausea—Prednisolone—ulcerative colitis	4.98e-05	0.0005	CcSEcCtD
Montelukast—Pruritus—Dexamethasone—ulcerative colitis	4.95e-05	0.000497	CcSEcCtD
Montelukast—Pruritus—Betamethasone—ulcerative colitis	4.95e-05	0.000497	CcSEcCtD
Montelukast—Vomiting—Triamcinolone—ulcerative colitis	4.9e-05	0.000493	CcSEcCtD
Montelukast—Vomiting—Methylprednisolone—ulcerative colitis	4.89e-05	0.000491	CcSEcCtD
Montelukast—Nausea—Hydrocortisone—ulcerative colitis	4.86e-05	0.000489	CcSEcCtD
Montelukast—Rash—Triamcinolone—ulcerative colitis	4.86e-05	0.000488	CcSEcCtD
Montelukast—Dermatitis—Triamcinolone—ulcerative colitis	4.85e-05	0.000488	CcSEcCtD
Montelukast—Rash—Methylprednisolone—ulcerative colitis	4.85e-05	0.000487	CcSEcCtD
Montelukast—Dermatitis—Methylprednisolone—ulcerative colitis	4.84e-05	0.000487	CcSEcCtD
Montelukast—Urticaria—Prednisone—ulcerative colitis	4.84e-05	0.000486	CcSEcCtD
Montelukast—Headache—Triamcinolone—ulcerative colitis	4.83e-05	0.000485	CcSEcCtD
Montelukast—Headache—Methylprednisolone—ulcerative colitis	4.82e-05	0.000484	CcSEcCtD
Montelukast—Abdominal pain—Prednisone—ulcerative colitis	4.81e-05	0.000484	CcSEcCtD
Montelukast—Body temperature increased—Prednisone—ulcerative colitis	4.81e-05	0.000484	CcSEcCtD
Montelukast—Diarrhoea—Betamethasone—ulcerative colitis	4.78e-05	0.000481	CcSEcCtD
Montelukast—Diarrhoea—Dexamethasone—ulcerative colitis	4.78e-05	0.000481	CcSEcCtD
Montelukast—CYSLTR1—Signaling by GPCR—CCR6—ulcerative colitis	4.74e-05	0.00274	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—IL6—ulcerative colitis	4.69e-05	0.00271	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—DLD—ulcerative colitis	4.65e-05	0.00269	CbGpPWpGaD
Montelukast—Dizziness—Betamethasone—ulcerative colitis	4.62e-05	0.000465	CcSEcCtD
Montelukast—Dizziness—Dexamethasone—ulcerative colitis	4.62e-05	0.000465	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—SEL1L—ulcerative colitis	4.62e-05	0.00267	CbGpPWpGaD
Montelukast—CYP2A6—Fluoropyrimidine Activity—TP53—ulcerative colitis	4.61e-05	0.00266	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PTGER4—ulcerative colitis	4.59e-05	0.00265	CbGpPWpGaD
Montelukast—Nausea—Triamcinolone—ulcerative colitis	4.58e-05	0.00046	CcSEcCtD
Montelukast—Nausea—Methylprednisolone—ulcerative colitis	4.57e-05	0.000459	CcSEcCtD
Montelukast—Hypersensitivity—Prednisone—ulcerative colitis	4.49e-05	0.000451	CcSEcCtD
Montelukast—Vomiting—Dexamethasone—ulcerative colitis	4.45e-05	0.000447	CcSEcCtD
Montelukast—Vomiting—Betamethasone—ulcerative colitis	4.45e-05	0.000447	CcSEcCtD
Montelukast—Rash—Betamethasone—ulcerative colitis	4.41e-05	0.000443	CcSEcCtD
Montelukast—Rash—Dexamethasone—ulcerative colitis	4.41e-05	0.000443	CcSEcCtD
Montelukast—Dermatitis—Betamethasone—ulcerative colitis	4.4e-05	0.000443	CcSEcCtD
Montelukast—Dermatitis—Dexamethasone—ulcerative colitis	4.4e-05	0.000443	CcSEcCtD
Montelukast—Headache—Betamethasone—ulcerative colitis	4.38e-05	0.00044	CcSEcCtD
Montelukast—Headache—Dexamethasone—ulcerative colitis	4.38e-05	0.00044	CcSEcCtD
Montelukast—Asthenia—Prednisone—ulcerative colitis	4.37e-05	0.000439	CcSEcCtD
Montelukast—Pruritus—Prednisone—ulcerative colitis	4.31e-05	0.000433	CcSEcCtD
Montelukast—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	4.27e-05	0.00247	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—GHRL—ulcerative colitis	4.2e-05	0.00243	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PTGER4—ulcerative colitis	4.17e-05	0.00241	CbGpPWpGaD
Montelukast—Diarrhoea—Prednisone—ulcerative colitis	4.17e-05	0.000419	CcSEcCtD
Montelukast—Nausea—Betamethasone—ulcerative colitis	4.15e-05	0.000418	CcSEcCtD
Montelukast—Nausea—Dexamethasone—ulcerative colitis	4.15e-05	0.000418	CcSEcCtD
Montelukast—Dizziness—Prednisone—ulcerative colitis	4.03e-05	0.000405	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.9e-05	0.00226	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	3.89e-05	0.00225	CbGpPWpGaD
Montelukast—Vomiting—Prednisone—ulcerative colitis	3.87e-05	0.000389	CcSEcCtD
Montelukast—SLCO2B1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	3.84e-05	0.00222	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	3.84e-05	0.00222	CbGpPWpGaD
Montelukast—Rash—Prednisone—ulcerative colitis	3.84e-05	0.000386	CcSEcCtD
Montelukast—Dermatitis—Prednisone—ulcerative colitis	3.84e-05	0.000386	CcSEcCtD
Montelukast—CYSLTR1—Signaling by GPCR—GHRL—ulcerative colitis	3.82e-05	0.00221	CbGpPWpGaD
Montelukast—Headache—Prednisone—ulcerative colitis	3.81e-05	0.000384	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—CXCR1—ulcerative colitis	3.8e-05	0.0022	CbGpPWpGaD
Montelukast—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.79e-05	0.00219	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	3.73e-05	0.00216	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.72e-05	0.00215	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CALM3—ulcerative colitis	3.7e-05	0.00214	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	3.68e-05	0.00213	CbGpPWpGaD
Montelukast—Nausea—Prednisone—ulcerative colitis	3.62e-05	0.000364	CcSEcCtD
Montelukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	3.52e-05	0.00204	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—ADRB2—ulcerative colitis	3.48e-05	0.00201	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	3.47e-05	0.00201	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCL20—ulcerative colitis	3.34e-05	0.00193	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	3.24e-05	0.00187	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—ADRB2—ulcerative colitis	3.16e-05	0.00183	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GNA12—ulcerative colitis	3.14e-05	0.00181	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.12e-05	0.0018	CbGpPWpGaD
Montelukast—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.09e-05	0.00178	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	3e-05	0.00173	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CXCR2—ulcerative colitis	2.98e-05	0.00172	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—CXCL8—ulcerative colitis	2.97e-05	0.00172	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	2.96e-05	0.00171	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.95e-05	0.00171	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.91e-05	0.00168	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCR6—ulcerative colitis	2.8e-05	0.00162	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—ADCY5—ulcerative colitis	2.68e-05	0.00155	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAML2—ulcerative colitis	2.65e-05	0.00153	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	2.52e-05	0.00146	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTGER4—ulcerative colitis	2.46e-05	0.00142	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.46e-05	0.00142	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CHP1—ulcerative colitis	2.34e-05	0.00135	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GHRL—ulcerative colitis	2.25e-05	0.0013	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS1—ulcerative colitis	2.25e-05	0.0013	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.21e-05	0.00128	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CHP1—ulcerative colitis	2.21e-05	0.00128	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CALM3—ulcerative colitis	2.18e-05	0.00126	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RIPK2—ulcerative colitis	2.15e-05	0.00124	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	2.03e-05	0.00118	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CALM3—ulcerative colitis	2.02e-05	0.00117	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—DLD—ulcerative colitis	2.02e-05	0.00117	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.98e-05	0.00114	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.95e-05	0.00113	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.93e-05	0.00112	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—DLD—ulcerative colitis	1.91e-05	0.0011	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ADRB2—ulcerative colitis	1.87e-05	0.00108	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—JAK2—ulcerative colitis	1.84e-05	0.00106	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—TGFB1—ulcerative colitis	1.7e-05	0.000984	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.68e-05	0.000971	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—JAK2—ulcerative colitis	1.67e-05	0.000966	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—IL2—ulcerative colitis	1.61e-05	0.000928	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ADCY5—ulcerative colitis	1.58e-05	0.000916	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ABCB1—ulcerative colitis	1.57e-05	0.00091	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CXCL8—ulcerative colitis	1.53e-05	0.000882	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.51e-05	0.000872	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ADCY5—ulcerative colitis	1.47e-05	0.000849	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL2—ulcerative colitis	1.46e-05	0.000843	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.41e-05	0.000817	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—DLD—ulcerative colitis	1.3e-05	0.000753	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.23e-05	0.00071	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.15e-05	0.000665	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARG—ulcerative colitis	1.1e-05	0.000633	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.07e-05	0.000616	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—DLD—ulcerative colitis	1.06e-05	0.000613	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JAK2—ulcerative colitis	9.88e-06	0.000571	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ALB—ulcerative colitis	9.85e-06	0.000569	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.59e-06	0.000554	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RELA—ulcerative colitis	9.57e-06	0.000553	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS1—ulcerative colitis	9.22e-06	0.000533	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CXCL8—ulcerative colitis	9.01e-06	0.000521	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CALM3—ulcerative colitis	8.78e-06	0.000507	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—ulcerative colitis	8.62e-06	0.000498	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—ulcerative colitis	8.62e-06	0.000498	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—ulcerative colitis	8.57e-06	0.000495	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.39e-06	0.000485	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CALM3—ulcerative colitis	8.3e-06	0.00048	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP9—ulcerative colitis	8.15e-06	0.000471	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CHP1—ulcerative colitis	8.1e-06	0.000468	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NFKB1—ulcerative colitis	8.07e-06	0.000466	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—ulcerative colitis	7.25e-06	0.000419	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—DLD—ulcerative colitis	6.99e-06	0.000404	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.89e-06	0.000398	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCB1—ulcerative colitis	6.83e-06	0.000394	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—ulcerative colitis	6.72e-06	0.000388	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCB1—ulcerative colitis	6.45e-06	0.000373	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ADCY5—ulcerative colitis	6.37e-06	0.000368	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS1—ulcerative colitis	6.3e-06	0.000364	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.19e-06	0.000358	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ADCY5—ulcerative colitis	6.02e-06	0.000348	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CALM3—ulcerative colitis	5.67e-06	0.000328	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.61e-06	0.000324	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—ulcerative colitis	5.53e-06	0.00032	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.42e-06	0.000313	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS1—ulcerative colitis	5.12e-06	0.000296	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—ulcerative colitis	5.06e-06	0.000293	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.04e-06	0.000291	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—ulcerative colitis	4.75e-06	0.000274	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CALM3—ulcerative colitis	4.61e-06	0.000267	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—ulcerative colitis	4.49e-06	0.000259	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.41e-06	0.000255	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCB1—ulcerative colitis	4.41e-06	0.000255	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—ulcerative colitis	4.27e-06	0.000247	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.11e-06	0.000238	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—ulcerative colitis	4.04e-06	0.000233	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—ulcerative colitis	3.74e-06	0.000216	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCB1—ulcerative colitis	3.59e-06	0.000207	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—ulcerative colitis	3.53e-06	0.000204	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.38e-06	0.000195	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.35e-06	0.000193	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.07e-06	0.000177	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.04e-06	0.000176	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—ulcerative colitis	2.76e-06	0.000159	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.5e-06	0.000144	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.41e-06	0.000139	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.37e-06	0.000137	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—ulcerative colitis	2.24e-06	0.00013	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.21e-06	0.000128	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.96e-06	0.000113	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.65e-06	9.51e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—ulcerative colitis	1.48e-06	8.55e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.3e-06	7.48e-05	CbGpPWpGaD
